An inhalable drug treatment for chronic obstructive pulmonary disease received FDA-approval June 26, drugmaker Verona Pharma announced.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
An inhalable drug treatment for chronic obstructive pulmonary disease received FDA-approval June 26, drugmaker Verona Pharma announced.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis